Biochemical diagnosis of pheochromocytoma: Which test is best?

JAMA

Volumn 287, Issue 11, 2002, Pages 1427-1434

  Lenders, Jacques W M ^a   Pacak, Karel ^d   Walther, McClellan M ^e   Marston Linehan, W ^e   Mannelli, Massimo ^b   Friberg, Peter ^c   Keiser, Harry R ^f   Goldstein, David S ^g   Eisenhofer, Graeme ^g  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; METADRENALIN; VANILMANDELIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TUMOR DIAGNOSIS;

EID: 0037139449     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma
2. Pheochromocytoma: Current diagnosis and management
3. Diagnostic problems in pheochromocytoma
4. Circulating and urinary catecholamines in pheochromocytoma
5. Measurement of norepinephrine and 3,4-dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma
6. Biochemical tests for pheochromocytoma: Strategies in hypertensive patients
7. Biochemical detection of phaechromocytoma
8. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma
9. Plasma metanephrines in the diagnosis of pheochromocytoma
10. The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma
11. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2
12. Pheochromocytoma in Italy: A multicentric retrospective study
13. Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice
14. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma
15. A five-year report on experience in the detection of pheochromocytoma
16. Lessons from an unpleasant surprise
17. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase
18. Determination of catecholamines in human plasma by high-performance liquid chromatography
19. Determination of plasma metanephrines by liquid chromatography with electrochemical detection
20. A simple analysis of normetanephrine and metanephrine in urine
21. Determination of 3-methoxy-4-hydroxymandelic acid in urine
22. Analysis for urinary catecholamines by liquid chromatography with amperometric detection
23. The use of relative operating characteristic (ROC) curves in test performance evaluation
24. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
25. Plasma metadrenalines
26. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines
27. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors
28. Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma
29. Mesenteric organ production, hepatic metabolism, and renal elimination of norepinephrine and its metabolites in humans
30. Free or total metanephrines for diagnosis of pheochromocytoma: What is the difference?
31. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families
32. Interpreting hoof-beats
33. Clonidine-suppression test
34. Glucagon and clonidine testing in the diagnosis of pheochromocytoma
35. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
36. Dihydrocaffeic acid: A common contaminant in the liquid chromatographic-electrochemical measurement of plasma catecholamines in man